BridgeBio Pharma Inc (OQ:BBIO)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for BBIO within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 21st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 12/20 Daniels Ronald J Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 91,554  
Feb 14/20 Feb 12/20 Momtazee James C Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 24,927  
Feb 14/20 Feb 12/20 Momtazee James C Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 8,491  
Feb 13/20 Feb 11/20 Turtle Cameron Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,000  
Feb 13/20 Feb 11/20 Turtle Cameron Direct Ownership Common Stock S - Open market or private sale -2,000 $37.28
Feb 13/20 Feb 11/20 Turtle Cameron Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,000 $17.00
Feb 12/20 Feb 10/20 Homcy Charles J Direct Ownership Common Stock S - Open market or private sale -20,000 $36.00
Feb 7/20 Feb 5/20 Kumar Neil Indirect Ownership Common Stock S - Open market or private sale -30,893 $34.87
Feb 5/20 Feb 4/20 Kumar Neil Indirect Ownership Common Stock S - Open market or private sale -54,951 $34.55
Feb 5/20 Feb 4/20 Stephenson Brian C Direct Ownership Common Stock S - Open market or private sale -4,973 $34.52
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BBIO within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 21st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 12/20 Daniels Ronald J Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 91,554  
Feb 14/20 Feb 12/20 Momtazee James C Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 24,927  
Feb 14/20 Feb 12/20 Momtazee James C Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 8,491  
Feb 14/20 Dec 30/19 Kumar Neil Direct Ownership Common Stock Form 5/A : Amendment of a previous Form 5 66,730  
Feb 14/20 Dec 30/19 Kumar Neil Indirect Ownership Common Stock Form 5/A : Amendment of a previous Form 5 -400,375  
Feb 13/20 Dec 30/19 Kumar Neil Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities 66,730  
Feb 13/20 Dec 30/19 Kumar Neil Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -400,375  
Feb 13/20 Feb 11/20 Turtle Cameron Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,000  
Feb 13/20 Feb 11/20 Turtle Cameron Direct Ownership Common Stock S - Open market or private sale -2,000 $37.28
Feb 13/20 Feb 11/20 Turtle Cameron Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,000 $17.00
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $BBIO

Competitors

Competitors with Recent Insider Filings
Horizon Therapeutics PLC (OQ:HZNP)
Arvinas (OQ:ARVN)
Sanara Medtech (PK:SMTI)